George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 463.80
Bid: 462.90
Ask: 463.10
Change: 5.30 (1.16%)
Spread: 0.20 (0.043%)
Open: 463.80
High: 464.40
Low: 460.30
Prev. Close: 458.50
AV. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Aviva plc 2022 Results Announcement

9 Mar 2023 07:00

RNS Number : 3724S
Aviva PLC
09 March 2023
 

Page 1

 

News release

 

 

 

 

9 March 2023

 

 

 

 

Aviva plc 2022 Results Announcement

Strong 2022 results, operating momentum continues

Announcing share buyback of £300m1. Total capital return over £5bn since 2021

On track to meet or exceed Group targets, outlook remains positive

Solvency II OFG‡

Solvency II cover ratio‡,3

 

General insurance COR‡

 

Operating

profit‡,4

 

Baseline controllable costs‡,5

£1,623m

 

212%

 

94.6%

 

£2,213m

 

£2,771m

+37%

 

(32)pp

 

+1.7pp

 

+35%

 

(3)%

20212: £1,187m

 

2021: 244%

 

20212: 92.9%

 

20212: £1,634m

 

20212: £2,854m

 

Amanda Blanc, Group Chief Executive Officer, said:

"We are making excellent progress at Aviva. Operating profits and dividends are growing and we have strong trading momentum despite significant market volatility. We have radically simplified Aviva, we are financially strong and we are utterly focused on transforming and growing the business.

"Our core businesses in the UK, Ireland and Canada grew in 2022, and contributed to a very strong, all round performance. Life insurance value of new business is up 15%, general insurance sales6,7 are up 8% and overall operating profit is up 35%. We are investing to make it easier for customers to do business with Aviva and customer numbers in the UK have grown to 15.5m.

"Cash remittances2 are up strongly, our capital position is robust, and we are today declaring a final dividend of 20.7 pence, meaning a total ordinary dividend of 31.0 pence for 2022. We are committed to delivering an attractive and sustainable dividend, and have upgraded our dividend guidance to low-to-mid single digit growth in the cash cost of the dividend. We are confident in the future capital generation of our business, and so we are also announcing today an additional return of capital to shareholders, via the launch of a £300m share buyback, in line with our preference to return surplus capital regularly and sustainably. This takes the total capital return to over £5bn since 2021.

"The diversified model we have built at Aviva has proved its worth, providing clear benefits for customers and shareholders and driving our great results last year. Whilst I am pleased with what's been accomplished over the past twelve months, I am clear there is significantly more value which Aviva can and will deliver in 2023 and beyond."

Strong results demonstrating benefits of diversified business model

• General insurance gross written premiums (GWP) up 8%7 to £9,749m (20212: £8,807m) and COR‡ of 94.6% (20212: 92.9%)

UK & Ireland Life VNB‡ up 15% to £767m (2021: £668m) with sales6 of £33bn (2021: £36bn)

Operating profit‡,4 up 35% to £2,213m (20212: £1,634m)

Solvency II operating own funds generation‡ up 37% to £1,623m (20212: £1,187m)

Solvency II return on equity‡ 16.4% (20212: 10.7%)

• Cash remittances‡ up 11% to £1,845m (20212: £1,662m)

• Baseline controllable costs‡,5 down 3% to £2,771m (20212: £2,854m) reflecting continued focus on efficiency

• IFRS loss of £(1,139)m (2021: £2,036m profit) largely reflects adverse market movements

• Final dividend per share of 20.70p (2021: 14.70p). Total dividend per share of 31.00p (2021: 22.05p), as per previous guidance

Capital position remains robust - £300m share buyback to commence immediately

• Solvency II shareholder cover ratio‡ of 212% (2021: 244%) and centre liquidity‡ (Feb 23) of £2.2bn (Feb 22: £6.6bn)

• Estimated Solvency II shareholder cover ratio pro forma for further debt reduction and pension scheme payment of 207%. Allowing for payment of the 2022 final dividend and the £300m share buyback the ratio is estimated at 196%.

• Solvency II debt leverage ratio‡ of 31% (2021: 27%), and 30% on a pro forma basis for further debt reduction and pension scheme payment.

• Given our robust capital position, we are commencing a £300m share buyback programme immediately1. Our preference remains to return surplus capital regularly and sustainably.

 

 

 

 

 

Footnotes are shown on page 2

 

Page 2

Continuing strong operating momentum

• Wealth proved resilient in challenging market conditions with net flows‡ of £9.1bn (2021: £10.0bn) benefitting from strong performance in Workplace which added 374 new schemes in the year.

• Annuities & Equity release sales6 were 21% lower at £6,238m (2021: £7,887m) with Solvency II OFG‡ up 34% to £524m(2021: £392m). The outlook for BPA volumes is positive and we are confident in meeting our £15-£20bn volume target over 2022-24.

• Protection & Health VNB‡ up 18% to £221m (2021: £188m) reflecting strong sales, improved margins and beneficial assumption changes, partly offset by the negative impact from higher interest rates.

• UK & Ireland General Insurance GWP, up 7% to £5,740m (2021: £5,352m), and COR‡ of 96.1% (2021: 94.3%). UK commercial lines performed strongly with GWP up 12% while personal lines was up 2% as we retained our pricing discipline amid adverse market conditions. We will continue to take the necessary actions to price appropriately for the inflationary environment in 2023.

• Canada GWP up 16% (9% at constant currency) to £4,009m (2021: £3,455m) and a COR‡ of 92.5% (2021: 90.7%). We saw excellent growth in both commercial and personal lines with GWP up 14% and 6% respectively at constant currency.

• Aviva Investors external net flows‡ remain positive despite challenging market conditions at £1.3bn (2021: £3.3bn).

 

Group financial performance

 

Cash and liquidity

 

 

 

 

 

 

 

 

 

General Insurance GWP

UK & IrelandLife VNB‡

 

IFRS loss

for the year

 

Cash remittances‡

 

Centre liquidity‡

£9.7bn

 

£767m

 

£(1,139)m

 

£1,845m

 

£2.2bn

+8%7

 

+15%

 

(156)%

 

+11%

 

£(4.4)bn

20212: £8.8bn

 

20212: £668m

 

2021: profit £2,036m

 

20212: £1,662m

 

Feb 22: £6.6bn

Outlook

Our positive momentum continued in 2022 with a strong set of results, and our diversified business model positions us well to navigate the current macroeconomic environment. This reinforces our confidence in the prospects, financial targets and outlook for the Group.

In UK & Ireland Life we expect higher BPA volumes in 2023 as a growing number of pension schemes look to de-risk. Our Wealth business remains positioned to grow, and while market conditions are challenging in the near-term in Adviser Platform, our Workplace business offers strong growth opportunities. We continue to expect good demand for Protection and Health products.

In General Insurance we will remain focused on pricing appropriately for the inflationary environment. In the UK, we expect to see continued momentum in commercial lines while we focus on growing our retail business in personal lines. In Canada, rates are expected to remain supportive in commercial lines along with personal property, while we continue to focus on managing rate in personal motor given the inflationary pressures, and growing our RBC partnership and direct business. Across General Insurance, we remain focused on meeting our 8 CORambition over time.

Aviva Investors continues to focus on improving efficiency across the business, and is taking actions to drive improvements. However, conditions are likely to remain challenging in 2023 given ongoing uncertainty in the macro environment and investment markets.

We are committed to delivering for our shareholders. We have set out a sustainable dividend policy, and expect to pay a dividend ofc.£915 million for 2023, with low-to-mid single digit growth in the cash cost of the dividend thereafter.

Under our capital framework, surplus capital is available for reinvestment in the business, focused M&A and returns to shareholders. We have announced a share buyback today, and anticipate further regular and sustainable capital returns in the future9.

 

 

 

 

 

‡ Denotes Alternative Performance Measures (APMs) and further information can be found in the 'Other information' section | 1. Commencing on 10th March 2023. | 2. Comparatives presented are from continuing operations | 3. Solvency II cover ratio is the estimated Solvency II shareholder cover ratio at 31 December 2022 | 4. Operating profit represents Group adjusted operating profit which is a non-GAAP APM. Operating profit is not bound by the requirements of IFRS. Further details are included in the 'Other information' section | 5. Baseline controllable costs exclude strategic investment, cost reduction implementation, IFRS 17 and other costs not included in the 2018 costs savings target baseline | 6. Sales refers to present value of new business premiums (PVNBP) in Life or gross written premiums (GWP) in General Insurance | 7. Constant currency | 8. Based on IFRS 4 | 9. The Board has not approved or made any decision to pay any dividend in respect of any future period

 

 

 

Click on, or paste the following links into your web browser, to view the complete Aviva plc Results Announcement 2022 and the Aviva plc Annual Report and Accounts 2022 documents:

http://www.rns-pdf.londonstockexchange.com/rns/3724S_1-2023-3-9.pdf

http://www.rns-pdf.londonstockexchange.com/rns/3724S_2-2023-3-9.pdf

 

The documents are available to view on the Company's website at https://www.aviva.com/investors/reports/ and copies have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FIFELVTIAIIV
Date   Source Headline
26th Apr 20241:53 pmRNSForm 8.3 - Tyman plc
26th Apr 20241:50 pmRNSForm 8.3 - International Paper Company
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20242:51 pmRNSForm 8.3 - Tyman plc
25th Apr 20242:51 pmRNSForm 8.3 - Tritax Big Box REIT plc
25th Apr 20242:49 pmRNSForm 8.3 - International Paper Company
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20242:40 pmRNSForm 8.3 - Tritax Big Box REIT PLC
24th Apr 20242:39 pmRNSForm 8.3 - Quanex Building Products Corporation
24th Apr 20242:37 pmRNSForm 8.3 - Tyman PLC
24th Apr 20241:37 pmRNSForm 8.3 - Smith (DS) plc
24th Apr 20241:07 pmRNSForm 8.3 - Spirent Communications plc
24th Apr 20241:00 pmRNSForm 8.3 - Balanced Commercial Property Trust
24th Apr 202412:50 pmRNSForm 8.3 - Mondi PLC Replacement
24th Apr 202412:48 pmRNSForm 8.3 - Tritax Big Box REIT plc Replacement
24th Apr 202412:46 pmRNSForm 8.3 - UK Commercial Property REIT Replacement
24th Apr 20247:00 amRNSInvestor and analyst briefing on Health business
23rd Apr 20244:00 pmRNSHolding(s) in Company
23rd Apr 20242:30 pmRNSForm 8.3 - International Paper Company
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20243:22 pmRNSHolding(s) in Company
22nd Apr 20242:29 pmRNSForm 8.3 - UK Commercial Property REIT Ltd
22nd Apr 20242:28 pmRNSForm 8.3 - Tritax Big Box REIT plc
22nd Apr 20242:26 pmRNSForm 8.3 - Spirent Communications plc
22nd Apr 20242:24 pmRNSForm 8.3 - Smith (DS) plc
22nd Apr 20242:22 pmRNSForm 8.3 - Mondi PLC
22nd Apr 20242:20 pmRNSForm 8.3 - International Paper Company
22nd Apr 20242:18 pmRNSForm 8.3 - Balanced Commercial Property Trust Ltd
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20242:25 pmRNSForm 8.3 - Tritax Big Box REIT PLC
19th Apr 20242:23 pmRNSForm 8.3 - Mondi PLC
19th Apr 20242:22 pmRNSForm 8.3 - International Paper Company
19th Apr 20242:21 pmRNSForm 8.3 - Balanced Commercial Property Trust Ltd
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20242:08 pmRNSForm 8.3 - Smith (DS) plc
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20242:28 pmRNSForm 8.3 - Mondi PLC
17th Apr 20249:00 amRNSDirectorate change & withdrawal of AGM resolution
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20242:10 pmRNSForm 8.3 - Tritax Big Box REIT plc
16th Apr 20242:07 pmRNSForm 8.3 - Smith (DS) plc
16th Apr 20242:04 pmRNSForm 8.3 - Mondi plc
16th Apr 20242:03 pmRNSForm 8.3 - Balanced Commercial Property Trust Ltd
16th Apr 202410:00 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20242:45 pmRNSForm 8.3 - Tritax Big Box REIT plc
15th Apr 20242:43 pmRNSForm 8.3 - Spirent Communications plc
15th Apr 20242:40 pmRNSForm 8.3 - Smith (DS) plc
15th Apr 20242:36 pmRNSForm 8.3 - Mondi plc
15th Apr 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.